Abstract:G-protein coupled receptor family C, group 5, member A, (GPRC5A) is a seven trans-membrane protein. The expression pattern of the GPRC5A gene is unique, almost exclusively in lung tissue. GPRC5A expression is frequently suppressed in human lung cancers, including lung adenocarcinoma. This suggests that inactivation of this gene may contribute to lung tumorigenesis. Indeed, we have previously found that knockout of both alleles of the mouse Gprc5a gene enhances spontaneous lung carcinogenesis. Lung epithelial cells isolated from lungs of knockout mice had a constitutively activated nuclear factor kappa B (NF-\#954;B) and tumors that developed in this model were associated with inflammatory cells. Because chronic inflammation and aberrant NF-\#954;B activation have been implicated in human lung carcinogenesis as well, in this study we explored the relationship between GPRC5A expression and NF-\#954;B activation. We found that re-expression of GPRC5A in human adenocarcinoma H1792 cells, which express low level of GPRC5A, inhibits tumor necrosis factor alpha-induced NF-\#954;B activation and suppresses the transformed phenotype (anchorage-independent growth). GPRC5A-mediated NF-\#954;B inhibition was also observed in human colon cancer cell line HCT116 and human embryonic kidney (HEK) 293 cells immortalized with sheared fragments of adenovirus (Ad)5 DNA. Inhibition of NF-\#954;B activity by GPRC5A was correlated with loss of anchorage-independent growth and increased anoikis. The mechanism of NF-\#954;B inhibition was associated with GPRC5A-mediated inhibition of I\#954;B\#945; degradation. Over-expression of GPRC5A resulted in increased formation of a complex containing \#946;-arrestin 2, I\#954;B\#945; and the NF-\#954;B subunit p65. Depletion of \#946;-arrestin 2 by siRNA restored NF-\#954;B activation in GPRC5A stable transfectants evidenced by expression of TRAF1 a downstream target of NF-\#954;B. This result suggests that increased interaction of \#946;-arrestin 2 with I\#954;B\#945;/p65 complex is involved in GPRC5A-mediated inhibition of NF-\#954;B. An analysis of 150 cases of human lung adenocarcinoma by immunohistochemical staining revealed that increased nuclear localization of NF-\#954;B indicating activation correlated with suppressed expression of GPRC5A. These results have led to the conclusion that GPRC5A functions as a physiological inhibitor of NF-\#954;B activation in lung tissue and thereby suppress carcinogenesis. Further, we propose that GPRC5A function as a tumor suppressor in human lung tissue because its deletion or repression of its expression leads to aberrant activation of NF-\#954;B pathway and tumorigenesis. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 5347.

GPRC5A: an Emerging Biomarker in Human Cancer

Advances in research of tumor-related gene GPRC5A

GPRC5A Suppresses Protein Synthesis at the Endoplasmic Reticulum to Prevent Radiation-Induced Lung Tumorigenesis

Prognostic and Clinicopathological Significance of GPRC5A in Various Cancers: A Systematic Review and Meta-Analysis

Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.

GPRC5A and Lung Cancer

GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancer

EGFR Phosphorylates and Inhibits Lung Tumor Suppressor GPRC5A in Lung Cancer.

GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical Significance

Abstract #5347: the Lung Tumor Suppressor GPRC5A Inhibits Activation of NF-\#954;B in Human Non-Small Cell Lung Adenocarcinoma Cells

10-14-2014 EGFR Phosphorylates and Inhibits Lung Tumor Suppressor GPRC 5 A in Lung Cancer

Repression Of G Protein-Coupled Receptor Family C Group 5 Member A Is Associated With Pathologic Differentiation Grade Of Oral Squamous Cell Carcinoma

GPRC5A Promotes Lung Colonization of Esophageal Squamous Cell Carcinoma

Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality

Identification of the Retinoic Acid-Inducible Gprc5a As a New Lung Tumor Suppressor Gene.

A Gprc5a Tumor Suppressor Loss of Expression Signature is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas

Elevation of GPRC5A Expression in Colorectal Cancer Promotes Tumor Progression Through VNN‐1 Induced Oxidative Stress

Repression of GPRC5A is Associated with Activated STAT3, Which Contributes to Tumor Progression of Head and Neck Squamous Cell Carcinoma.

GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer

Lung Cancer Suppressor Gene GPRC5A Mediates P53 Activity in Non-Small Cell Lung Cancer Cells in Vitro